Kiora Pharmaceuticals Inc (KPRX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $5.44M
Last updated: Nov 17, 2026 at 4:10 PM ET
Kiora Pharmaceuticals Inc (KPRX) Stock Chart
Kiora Pharmaceuticals (KPRX) has a latest price of $0.93 on Nov 17, 2026. Its price fell 56.9% over the past 12 months. The month-end price fell 100.0% over the 10 years through Oct 2026, a compound annual decline of 57.4%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $14,358.26 in Feb 2017 and its lowest $1.56 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart KPRX with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for KPRX.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 64.2%, and over 6 months it fell 63.1%. The month-end price fell 70.6% over the 3 years through Oct 2026, a compound annual decline of 33.5%.
| Period | Change |
|---|---|
| 1 month | -60.9% |
| 3 months | -64.2% |
| 6 months | -63.1% |
| 12 months | -56.9% |
| 12 months, with dividends | -56.9% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -70.6% | -33.5% |
| 5 years | -99.8% | -70.4% |
| 10 years | -100.0% | -57.4% |
Price by Year
Its best calendar year was 2019, when the price rose 43.7%, and its weakest was 2022, when it fell 94.3%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.56 | -20.8% |
| 2025 | $1.97 | -40.3% |
| 2024 | $3.30 | -29.8% |
| 2023 | $4.70 | -84.8% |
| 2022 | $30.87 | -94.3% |
| 2021 | $543.65 | -69.4% |
| 2020 | $1,774.98 | -50.8% |
| 2019 | $3,607.56 | +43.7% |
| 2018 | $2,510.54 | -56.5% |
| 2017 | $5,775.69 | -34.4% |
Trading Range
The price is 58.0% below its 50-day average of $2.21 and 60.7% below its 200-day average of $2.36.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.93 | |
| 50-day average | $2.21 | -58.0% |
| 200-day average | $2.36 | -60.7% |
Price Risk
Over 3 years, its largest fall from a peak was 87.8%.
| Measure | Value |
|---|---|
| 1-year beta | 1.39 |
| Largest fall, 1 year | -67.5% |
| Largest fall, 3 years | -87.8% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About KPRX
What is KPRX's 1-year price change?
Kiora Pharmaceuticals's price fell 56.9% over the past 12 months. With dividends included, the 12-month total return was -56.9%.
What is KPRX's 5-year price change?
Kiora Pharmaceuticals's month-end price fell 99.8% over the 5 years through Oct 2026, a compound annual decline of 70.4%. These figures leave out dividends.
What is KPRX's beta?
Kiora Pharmaceuticals's 1-year beta against the S&P 500 is 1.39, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 67.5%.
Is the KPRX chart free?
Yes. Advanced Charting for KPRX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
KPRX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors